SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBeacon Rise Regulatory News (BRS)

  • This share is currently suspended. It was suspended at a price of 160.00

Share Price Information for Beacon Rise (BRS)

Share Price is delayed by 15 minutes
Get Live Data
160.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £2.48m
BRS Live PriceLast checked at - London Stock Exchange

Intraday Beacon Rise Share Chart

Update in relation to ProActive

1 May 2026 08:24

RNS Number : 7818C
Beacon Rise Holdings PLC
01 May 2026
 

The information contained within this announcement was deemed by the Company to constitute inside information as stipulated under the UK Market Abuse Regulation

 

1 May 2026

 

Beacon Rise Holdings Plc

("Beacon Rise" or the "Company")

 

Update in relation to the Proposed Training-provider Acquisition

 

On 21 October 2025 Beacon Rise (LSE: BRS) announced that it had entered non-binding heads of terms save for exclusivity and other customary terms in relation to the proposed acquisition of the entire issued and to be issued share capital of ProActive Training Ltd (the "Training-provider" or "ProActive") by the Company for a consideration of approximately £1.35 million (the "Proposed Training-provider Acquisition").

 

Following irreconcilable disagreements in relation to certain key commercial terms and ultimately the valuation of ProActive, the board of directors of Beacon Rise (the "Board" or the "Directors") have concluded that it would not be in the best interest of the Company's shareholders to pursue the Proposed Training-provider Acquisition. Accordingly, the Board has terminated discussions in relation to the Proposed Training-provider Acquisition.

 

The Company continues to progress due diligence in relation to the two other previously announced proposed acquisitions, being the Proposed Ergotec Acquisition and the Proposed Chiropractor Acquisition. Related to this, the Company further reports that considerable progress has been made by the Company and its advisers in relation to finalising the necessary transaction documentation in relation to Admission.

 

Temporary suspension of listing and trading of Ordinary Shares

 

The Proposed Ergotec Acquisition and the Proposed Chiropractor Acquisition (together the "Proposed Acquisitions") are respectively classified as an "initial transaction" under UK Listing Rules ("UKLR") 13.4. In accordance with UKLR 21.1.4 and 21.3, the Company ordinary shares of £0.0001 each (ISIN: GB00BMC0V753) will remain suspended from its listing on the equity shares (shell companies) category of the Official List of the FCA and from trading on the Main Market of the London Stock Exchange.

 

Should final terms for any of the proposed acquisitions be agreed, the Company will issue an announcement with further details pursuant to UKLR 13.4.22R and UKLR 13.4.23R.

 

There can be no certainty that the Proposed Acquisitions will successfully complete, nor as to the final terms or timing of the Proposed Acquisitions. If the Proposed Acquisitions do not complete for any reason, it is expected that the suspension of the Company's listing on the Official List will be lifted, subject to FCA approval, and trading in the Company's shares on the Main Market of the London Stock Exchange will recommence.

 

Furthermore, it remains the case that each of the proposed acquisitions are separate and not inter-conditional. Accordingly, each of the proposed acquisitions will not be impacted by either failing to complete for any reason.

 

The Company will seek to simultaneously enter into final binding acquisition agreements in respect of the Proposed Acquisitions prior to Cancellation and Admission. However, the Company intends to proceed with Cancellation and Admission should a final binding acquisition agreement be agreed in relation to at least one of the proposed acquisitions.

 

The Company will release further announcements as and when appropriate.

 

Unless otherwise defined, definitions contained in this announcement have the same meaning as set out in the Company's notification on 29 September 2025 at 8:11 a.m.

 

Enquiries:

Beacon Rise Holdings Plc

Xiaobing Wang, Chief Executive Officer & Director

 

info@beaconrise.uk

Allenby Capital Limited - Sponsor and Financial Adviser

John Depasquale / Vivek Bhardwaj / Ashur Joseph

 Tel: +44 (0)20 3328 5656

info@allenbycapital.com

LDC Nominee Secretary Limited - Company Secretary

 

beaconrisecss@lawdeb.com

Legal Entity Identifier (LEI)

2138007PIYMZMBWD4M27

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQUAUBRNUUVRRR
12
Date   Source Headline
21st Mar 20251:09 pmRNSResult of EGM
4th Mar 20254:42 pmRNSNotice of GM
5th Sep 20243:10 pmRNSHalf-year Report
13th Jun 20242:56 pmRNSResult of AGM
10th May 20243:20 pmRNSNotice of AGM
25th Apr 202411:22 amRNSAnnual Financial Report
28th Feb 20242:54 pmRNSResult of EGM
21st Feb 20242:29 pmRNSTotal Voting Rights
21st Feb 20241:58 pmRNSHolding(s) in Company
21st Feb 20241:55 pmRNSHolding(s) in Company
14th Feb 202410:29 amRNSIssue of Equity
13th Feb 20247:00 amRNSNotice of EGM
20th Dec 20237:00 amRNSHalf-year Report
10th Oct 202310:33 amRNSChange of accounting reference date
27th Sep 20232:57 pmRNSDirectorate Change
20th Sep 20231:04 pmRNSResult of AGM
25th Aug 202310:20 amRNSNotice of AGM
21st Aug 20234:37 pmRNSRestoration of Listing
17th Aug 20234:29 pmRNSAnnual Financial Report
1st Aug 20237:43 amRNSDelay to publication of annual report
19th Apr 20234:51 pmRNSNotice of Extraordinary General Meeting
22nd Dec 202212:16 pmRNSHalf-year Report
31st Aug 20224:04 pmRNSHolding(s) in Company
9th Aug 20221:43 pmRNSAnnual Financial Report
29th Mar 20221:49 pmRNSAdmission to the Official List
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.